Posts in category: Uncategorized

Following a low-carbohydrate diet comprised primarily of plant-based foods was significantly associated with lower risk of premature death among people with type 2 diabetes, according to a new study led by researchers at Harvard T.H. Chan School of Public Health. It is the first prospective cohort study to examine the relationship between low-carbohydrate diet patterns and mortality among people with diagnosed type 2 diabetes.

A survey of more than 2,500 teens and young adults led by the American Heart Association has found that vaping nicotine and THC, the psychoactive component in marijuana, was associated with self-reported symptoms of depression and anxiety.

Health impacts students’ ability to learn. Leaders at MUSC’s Boeing Center for Children’s Wellness (MUSC BCCW) believe that lessons on healthy living can be part of every student’s school experience.

A long-established Alzheimer’s drug can help people with a disorder that causes them to compulsively pull at their hair or pick at their skin, a new clinical trial has concluded.

An intervention increases prevention but not treatment engagement for alcohol use disorder (AUD) in primary care, according to a study published online Feb. 27 in JAMA Internal Medicine.

Individuals with psoriasis have double the odds of having celiac disease (CD) versus individuals without psoriasis, according to a research letter published online Feb. 9 in the Journal of the American Academy of Dermatology.

The U.S. Food and Drug Administration said Tuesday that it has taken action to restrict imports of the veterinary tranquilizer xylazine to prevent illicit use of the drug.

A study from the University of Illinois Chicago links precarious work with increases in body mass index. The study adds to a growing body of evidence that precarious work may contribute to poor health outcomes. 

As the United States becomes increasingly more diverse, a growing number of patients are seeking specialized dermatologic care for skin and hair conditions unique to their ethnic backgrounds.

Advanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patients with this disease present alterations in the MET gene that encodes a hepatocyte growth factor receptor. Mutations in this gene are implicated in disease progression and can also contribute to cancer drug resistance. While the association of MET mutations with the development of this kidney cancer subtype has been well described, the effect of specifically targeting this gene is unclear.